The OG Skin School

Neuromodulators / Botox

A closer look at the science-backed treatment for expression lines and facial rejuvenation.

Reviewed by Tish Manuel, RN, CRNA, MSN · Last updated July 2026

The Patient Guide

Plain-language answers to the questions we hear most.

What are neuromodulators, and how are they different from fillers?

Neuromodulators (Botox, Dysport, Xeomin, Jeuveau, and similar products) are all forms of botulinum toxin type A. They temporarily relax the small facial muscles that cause expression lines — frown lines, forehead lines, and crow's feet. Dermal fillers work differently: they add volume rather than relaxing muscles. Many patients use both, but they solve different problems.

How It Works

Botulinum toxin binds to nerve endings at the junction where nerves meet muscle and blocks the release of acetylcholine, the chemical signal that tells a muscle to contract. With that signal interrupted, the targeted muscle relaxes. Because many facial lines form from repeated muscle movement, relaxing the underlying muscle allows the skin above it to stay smoother. The effect is localized and always temporary, which is why touch-up treatments are needed every few months to maintain results.

What to Expect

Most patients describe treatment as a series of quick pinches, taking about 10–15 minutes with no downtime required. Onset is gradual — initial softening within 3–7 days, full effect by about 2 weeks. Results typically last 3–4 months, and most people schedule their next visit before the effect has fully faded. Mild redness or bruising at the injection sites is possible but not typical.

Is Botox Safe? What Are the Side Effects?

For appropriately dosed, properly administered cosmetic treatment, botulinum toxin has a well-established safety record spanning more than two decades of use. Common side effects are mild and temporary: injection-site redness, bruising, or headache. Rare side effects, such as eyelid or brow drooping, are uncommon with correct technique and resolve on their own as the effect wears off.

Who Shouldn't Get Botox?

Neuromodulators aren't recommended during pregnancy or breastfeeding, and they require caution in anyone with a neuromuscular condition such as myasthenia gravis or ALS. A thorough health history at your consultation is how we screen for these factors.

Is "Preventative" Botox in Your 20s Worth It?

The evidence is mixed and depends on the person. Younger patients with visible dynamic lines can benefit from low-dose, early treatment, and some research suggests this may slow the development of static lines over time. But there's no evidence that treating a naturally smooth, unlined face provides any added benefit — the decision should be based on what your face is actually doing, not your age alone.

Can Neuromodulators Treat More Than Cosmetic Concerns?

Yes — botulinum toxin has several FDA-approved and well-supported medical uses beyond expression lines. It's FDA-approved for chronic migraine prevention, using a specific injection pattern across the head and neck to reduce headache frequency in adults who experience migraines on 15 or more days a month. It's also FDA-approved for excessive sweating (hyperhidrosis), most commonly in the underarms, by blocking the nerve signals that activate sweat glands. For jaw tension, clenching, and teeth grinding (bruxism), injecting the masseter muscle is a widely used off-label option that can ease pain and pressure — and as a side benefit, often softens the appearance of a square jawline over time. If you're dealing with any of these, it's worth mentioning at your consultation so we can talk through whether it's a fit for you.

The Evidence

At The OG Skin Studio, our treatment recommendations are guided by current scientific literature, clinical expertise, and individualized patient assessment. Below are studies that have helped shape our understanding of botulinum toxin and its role in facial aesthetics.

The Foundation: How Botulinum Toxin Works

What researchers found: Botulinum toxin binds irreversibly to presynaptic nerve terminals and blocks the release of acetylcholine, the neurotransmitter responsible for triggering muscle contraction, through disruption of the SNARE protein complex that normally allows this signal to be released.

Why it matters: Understanding this precise, localized mechanism explains why effects are temporary, reversible, and confined to the treated muscle rather than affecting the nervous system broadly.

Read the study:
https://pubmed.ncbi.nlm.nih.gov/12887390/

Efficacy and Safety Across Facial Applications

What researchers found: A systematic review of botulinum toxin A for facial esthetic indications concluded that treatment is effective and safe across the recommended dosage ranges studied in the literature.

Why it matters: This kind of pooled analysis, drawing on many individual trials, gives a more reliable picture of real-world safety and effectiveness than any single study alone.

Read the study:
https://pubmed.ncbi.nlm.nih.gov/34787249/

Glabellar Lines: The Gold-Standard Indication

What researchers found: A network meta-analysis comparing multiple FDA-approved botulinum toxin formulations for glabellar lines (frown lines between the brows) confirmed consistent efficacy and safety across products — the most rigorously studied cosmetic use of the treatment.

Why it matters: Glabellar lines are the original and most extensively researched cosmetic indication for botulinum toxin, giving patients a large, mature body of evidence to draw on.

Read the study:
https://pubmed.ncbi.nlm.nih.gov/36097079/

Long-Term Safety

What researchers found: A review of serious adverse events associated with both therapeutic and cosmetic botulinum toxin use found that serious complications are rare and occur far more often with therapeutic (high-dose, medical) use than with cosmetic dosing.

Why it matters: Understanding the real, if low, rate of serious events — and how it differs between medical and cosmetic use — allows for honest, informed consent rather than either dismissing or overstating risk.

Read the study:
https://pubmed.ncbi.nlm.nih.gov/25613637/

Patient-Reported Outcomes and Quality of Life

What researchers found: A systematic review of patient-reported outcomes found consistently high satisfaction with cosmetic botulinum toxin treatment, and separate research found that treatment significantly improved quality-of-life and self-esteem measures compared to placebo.

Why it matters: Cosmetic treatment isn't just about appearance in isolation — validated research shows a measurable impact on how patients feel day to day.

Read the study:
https://pubmed.ncbi.nlm.nih.gov/30893170/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780803/

Duration of Effect

What researchers found: Clinical review data shows the therapeutic effect on glabellar lines typically begins within the first weeks after injection and gradually declines between three and six months, with higher doses associated with somewhat longer duration.

Why it matters: Setting accurate expectations for how long results last helps patients plan maintenance treatments rather than being surprised when lines gradually return.

Read the study:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047945/

Safety in Pregnancy: Why It's Still Avoided

What researchers found: A review of documented pregnancy exposures — including cases of accidental exposure — found no clear evidence that botulinum toxin crosses the placenta or increases the risk of adverse fetal outcomes, though data remains limited.

Why it matters: Because the safety data, while reassuring, isn't extensive enough to rule out risk with confidence, cosmetic treatment during pregnancy or breastfeeding is avoided as a precaution rather than because of confirmed harm.

Read the study:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828093/

Treatment in Younger Patients

What researchers found: An evidence-based review of botulinum toxin use in young adults found the strongest supporting evidence for patients with visible dynamic lines, particularly in the glabellar and crow's feet regions, while noting a lack of evidence that treating unlined skin provides any preventive benefit.

Why it matters: This helps set honest expectations for younger patients curious about "preventative" treatment — the decision should be based on individual muscle activity and line formation, not age alone.

Read the study:
https://pubmed.ncbi.nlm.nih.gov/36445847/

Browse the Full Research Library

Prefer to explore the primary sources directly? Here is the complete, peer-reviewed reading list organized by topic.

Mechanism & General Overview
Efficacy
Safety
Patient-Reported Outcomes
Special Populations